Clot-selective coronary thrombolysis with tissue-type plasminogen activator, Science, vol.220, issue.4602, pp.220-1181, 1983. ,
DOI : 10.1126/science.6602378
Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology, Circulation, vol.69, issue.3, pp.69-605, 1984. ,
DOI : 10.1161/01.CIR.69.3.605
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction, pp.310-609, 1984. ,
Pulmonary thromboembolism, Harrison's Principles of Internal Medicine, pp.1561-1565, 2005. ,
Antithrombotic therapy in peripheral arterial occlusive disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy, Chest, issue.3, pp.126-609, 2004. ,
Mortality by cause for eight regions of the world: Global Burden of Disease Study, The Lancet, vol.349, issue.9061, pp.349-1269, 1997. ,
DOI : 10.1016/S0140-6736(96)07493-4
ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR, The Lancet, vol.328, issue.8512, pp.886-889, 1986. ,
DOI : 10.1016/S0140-6736(86)90411-3
Tissue Plasminogen Activator, Thrombolytic therapy, pp.171-207, 1987. ,
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris, Circulation, vol.75, issue.6, pp.75-1192, 1987. ,
DOI : 10.1161/01.CIR.75.6.1192
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator, European Journal of Biochemistry, vol.224, issue.2, pp.225-232, 1985. ,
DOI : 10.1016/0022-2836(84)90192-X
New plasminogen activators: A clinical review, Clinical Cardiology, vol.19, issue.3, pp.165-171, 1999. ,
DOI : 10.1002/clc.4960220303
Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the interuniversity cardiology institute in The Netherlands, Lancet, issue.28455, pp.578-82, 1985. ,
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli, Nature, vol.2, issue.5897, pp.301-214, 1983. ,
DOI : 10.1038/301214a0
Staphylokinase as a plasminogen activator component in recombinant fusion proteins, Applied and Environmental Microbiology, vol.65, issue.2, pp.506-513, 1999. ,
Production of tissue plasminogen activators from animal cells, Advances in Biochemical Engineering/Biotechnology, vol.34, pp.147-166, 1987. ,
DOI : 10.1007/BFb0000678
Expression of active human tissue-type plasminogen activator in escherichia coli, Applied and Environmental Microbiology, vol.64, issue.12, pp.4891-4896, 1998. ,
Expression of high levels of human tissue plasminogen activator in yeast under the control of an inducible GAL promoter, Applied Microbiology and Biotechnology, vol.37, issue.5, pp.604-608, 1992. ,
DOI : 10.1007/BF00240734
Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm, Proceedings of the National Academy of Sciences, vol.96, issue.24, pp.96-13703, 1999. ,
DOI : 10.1073/pnas.96.24.13703
Expression of highly disulfide???bonded proteins in Pichia pastoris, Structure, vol.2, issue.11, pp.1003-1005, 1994. ,
DOI : 10.1016/S0969-2126(94)00103-0
Recent Advances in the Expression of Foreign Genes in Pichia pastoris, Bio/Technology, vol.186, issue.8, pp.11-905, 1993. ,
DOI : 10.1146/annurev.bi.56.070187.004411
Review: methylotrophic yeasts as factories for the production of foreign proteins, Yeast, issue.14, pp.11-1331, 1995. ,
Current protocols in molecular biology, 1987. ,
DOI : 10.1002/0471142727
[45] Zymographic techniques for detection and characterization of microbial proteases, Methods in Enzymology, vol.235, pp.563-594, 1994. ,
DOI : 10.1016/0076-6879(94)35171-6
Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors, BioTechniques, vol.38, issue.1, pp.73-83, 2005. ,
DOI : 10.2144/05381RV01
Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae, Biotechnology and Applied Biochemistry, pp.48-55, 2007. ,
Advanced genetic strategies for recombinant protein expression in Escherichia coli, Journal of Biotechnology, vol.115, issue.2, pp.113-128, 2005. ,
DOI : 10.1016/j.jbiotec.2004.08.004
Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins, Microbial Cell Factories, vol.3, issue.1, p.11, 2004. ,
DOI : 10.1186/1475-2859-3-11
Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview, Microbial Cell Factories, vol.7, issue.1, 2008. ,
DOI : 10.1186/1475-2859-7-11
Plasminogen activators: A comparison, Vascular Pharmacology, vol.44, issue.1, pp.1-9, 2006. ,
DOI : 10.1016/j.vph.2005.09.003
Secretion of Active Human Tissue Plasminogen Activator from the Filamentous Fungus Aspergillus Nidulans, Bio/Technology, vol.33, issue.12, pp.1301-1304, 1987. ,
DOI : 10.1084/jem.148.1.223
Production of tissue plasminogen activator (t-PA) inAspergillus niger, Biotechnology and Bioengineering, vol.15, issue.2, pp.164-174, 2001. ,
DOI : 10.1002/bit.1156
Characterization and biological properties of recombinant tPA produced in Drosophila cells culture, Trends in Animal Cell Culture Technology, pp.161-166, 1990. ,
Tissue-type plasminogen activator: Characteristics, applications and production technology, Biotechnology Advances, vol.14, issue.3, pp.239-266, 1996. ,
DOI : 10.1016/0734-9750(96)00019-5
Heterologous protein production using thePichia pastoris expression system, Yeast, vol.24, issue.864, pp.249-270, 2005. ,
DOI : 10.1002/yea.1208
Recombinant Protein Production with Pichia pastoris in Continuous Fermentation ??? Kinetic Analysis of Growth and Product Formation, Engineering in Life Sciences, vol.2, issue.8, pp.229-235, 2002. ,
DOI : 10.1002/1618-2863(20020806)2:8<229::AID-ELSC229>3.0.CO;2-9
New selectable marker/auxotrophic host strain combinations for molecular genetic manipulation of Pichia pastoris, Gene, vol.263, issue.1-2, pp.159-169, 2001. ,
DOI : 10.1016/S0378-1119(00)00576-X
Design, total synthesis, and functional overexpression of the Candida rugosa lipl gene coding for a major industrial lipase, Protein Science, vol.11, issue.6, pp.1415-1422, 1998. ,
DOI : 10.1002/pro.5560070618
Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates, Analytical Biochemistry, vol.102, issue.1, pp.196-202, 1980. ,
DOI : 10.1016/0003-2697(80)90338-3
Rapid Differential Endogenous Plasminogen Activator Expression After Acute Middle Cerebral Artery Occlusion, Stroke, vol.32, issue.6, pp.32-1341, 2001. ,
DOI : 10.1161/01.STR.32.6.1341
Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cells, Gene, vol.33, issue.3, pp.33-279, 1985. ,
DOI : 10.1016/0378-1119(85)90235-5
Production of human tissue-type plasminogen activator in different mammalian cell lines using an Epstein-Barr virus vector, Journal of Biotechnology, vol.15, issue.1-2, pp.155-168, 1990. ,
DOI : 10.1016/0168-1656(90)90058-J